Supernus Pharmaceuticals
SUPN
SUPN
53 hedge funds and large institutions have $170M invested in Supernus Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.1%
New
53
Increased
–
Reduced
–
Closed
–
Calls
$5.84M
Puts
$869K
Net Calls
+$4.97M
Net Calls Change
+$4.97M
Top Buyers
1 |
NMC
1
NEA Management Company
Timonium,
Maryland
|
$68.5M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$30.5M |
3 |
A
3
Abingworth
London,
United Kingdom
|
$23.2M |
4 |
O
4
OrbiMed
New York
|
$16.1M |
5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$5.74M |
Top Sellers
No sellers this quarter